Risk factor
Significant default risk
Profitability factor
Favourable analyst view
About
Samil Pharmaceutical Co.,Ltd, a South Korean entity, is primarily engaged in manufacturing and distributing vital medical products. Its comprehensive pharmaceutical range addresses a wide array of health conditions, encompassing treatments for hepatic, gastrointestinal, cardiovascular (vasodilator, antithrombotic, circulatory), respiratory, musculoskeletal (skeletal muscle relaxants), neurological, and infectious diseases (antibiotics). The portfolio further extends to metabolic, allergic (antihistamines), immunological (immunosuppressive), endocrine (hormone), oncological (anti-tumor), urological, and ophthalmic disorders, alongside medications for fever, pain, and inflammation. Beyond prescription drugs, Samil Pharmaceutical also offers a selection of over-the-counter (OTC) products and personal hygiene supplies. Established in Seoul, South Korea, in 1947, the company maintains its headquarters there.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is overvalued on EV/EBITDA.
Target Price
The average target price of 000520.KS is 10000 and suggests 47.3% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation t